Construction of evaluation indicator system for selection of infectious disease prevention drugs

Published on Jun. 30, 2023Total Views: 1238 times Total Downloads: 383 times Download Mobile

Author: Dan HAN ¹ Yi-Bo DING ² Lei REN ¹ Ming-Ming GUO ¹  Li-Xin SHU ¹

Affiliation: 1. Demonstration Center of Military Medical Logistics, School of Pharmacy, Naval Medical University, Shanghai 200433, China 2. Department of Naval Epidemiology, School of Naval Medicine, Naval Medical University, Shanghai 200433, China

Keywords: Drug selection Infectious disease prevention Delphi method Indicator system

DOI: 10.19960/j.issn.1005-0698.202306005

Reference: Dan HAN, Yi-Bo DING, Lei REN, Ming-Ming GUO, Li-Xin SHU.Construction of evaluation indicator system for selection of infectious disease prevention drugs,2023, 32(6): 641-647.DOI: 10.19960/j.issn.1005-0698.202306005.[Article in Chinese]  Copied

Abstract
Full-text
References

Abstract

Objective To establish an evaluation indicator system for the selection of drugs for the prevention and control of infectious diseases.

Methods On the basis of literature research, 20 experts in relevant fields were invited to consult with Delphi method, the consultation results were analyzed, and the indicator system was established.

Results The positive coefficients of experts in the two rounds of expert consultation were 100%; the expert authority coefficients were 0.82 and 0.85 respectively; the coordination coefficients of experts were 0.476 and 0.578 respectively (P<0.05); the final indicator system consisted of 5 first-level indicators and 25 second-level indicators. The first-level indicators and their weights were effectiveness (0.3184), safety (0.2658), innovation (0.0579), accessibility (0.1316) and suitability (0.2263).

Conclusion The expert concentration and coordination degrees of the evaluation indicator system for the selection of infectious disease prevention drugs constructed by Delphi method are high, which can provide a reference basis for the selection of infectious disease prevention drugs.

Full-text

Please download the PDF version to read the full text: download

References

1.许庭莹, 石大伟, 刘东来, 等. WHO对年度优先关注突发传染病的评估方法介绍[J]. 传染病信息, 2019, 32(5): 385-389. [Xu TY, Shi DW, Liu DL, et al. Introduction to WHO's evaluation method of annual priority at-tention to sudden infectious diseases[J]. Infectious Disease Information, 2019, 32(5): 385-389.] DOI: 10.3969/j.issn.1007-8134.2019.05.001.

2.徐德铎, 金晓玲, 温燕, 等. 我国应急药品储备与使用管理的现状与思考[J].世界临床药物, 2022, 43(8): 993-997, 1032. [Xu DD, Jin XL, Wen Y, et al. Current situation and thinking of emergency drug storage and use management in China[J]. World Clinical Medicine, 2022, 43(8): 993-997, 1032.] DOI: 10.13683/j.wph.2022.08.006.

3.宋劲松,刘杰.我国大规模传染病应急产品产能储备研究[J].南京社会科学, 2020, (3): 28-36, 47. [Song JS, Liu J. Research on capacity reserve of large-scale infectious disease emergency products in China[J]. Nanjing Social Science, 2020, (3): 28-36, 47.] DOI: 10.15937/j.cnki.issn1001-8263.2020.03.005.

4.李正翔, 段蓉. 基于德尔菲法构建《医疗机构药品遴选指南》研究问题及药品遴选指标体系[J]. 中国医院药学杂志, 2020, 40(22): 2372-2376. [Li ZX, Duan R. Research issues and drug selection index system of the "Guidelines for Drug Selection in Medical Institutions" based on Delphi method[J]. Chinese Journal of Hospital Pharmacy, 2020, 40(22): 2372-2376.] DOI: 10.13286/j.1001-5213.2020.22.17.

5.肖熠, 伍红艳, 李梦楠, 等.德尔菲法在贵州省基本医疗保险药品价值评价指标体系构建中的应用[J].中国初级卫生保健, 2021, 35(6): 17-20, 24. [Xiao Y, Wu HY, Li MN, et al. The application of Delphi method in the con-struction of the evaluation index system of basic medical insurance drugs in Guizhou Province[J]. China Primary Health Care, 2021, 35(6): 17-20, 24.] DOI: 10.3969/j.issn.1001-568X.2021.06.0006.

6.苏广全, 陈慧, 桂双英, 等. 基于德尔菲法构建医疗机构药品目录管理评价指标体系[J]. 药物流行病学杂志, 2023, 32(1): 30-35. [Su GQ, Chen H, Gui SY, et al. Construction of the evaluation index system of drug cata-log management in medical institutions based on the Delphi method[J]. Chinese Journal of Phamaco-epidemiology, 2023, 32(1): 30-35.] DOI: 10.19960/j.issn.1005-0698.202301005.

7.翟宇瑶, 段万里, 薛小荣, 等. 基于德尔菲法构建中药注射剂临床应用评价指标体系的研究[J]. 药物流行病学杂志, 2021, 30(2): 110-115. [Zhai YY, Duan WL, Xue XR, et al. Study on the evaluation index system of clinical application of traditional Chinese medicine injections based on the Delphi method[J]. Chinese Journal of Phamacoepidemiology, 2021, 30(2): 110-115.] DOI: 10.19960/j.cnki.issn1005-0698.2021.02.007.

8.夏聪, 许军, 杨枭楠, 等.德尔菲法在上市后药品价值评价指标体系构建中的应用[J].中国卫生事业管理, 2017, 34(5): 358-360, 391. [Xia C, Xu J, Yang XN, et al. Application of Delphi method in the construction of post-marketing drug value evaluation index system[J]. Chinese Health Service Management, 2017, 34(5): 358-360, 391.] https://kns.cnki.net/kcms2/article/abstract?v=3uoqIhG8C44YLTlOAiTRKibYlV5Vjs7iAEhECQAQ9aTiC5BjCgn0RuBoKtgrZ4737-WPCJ8-4i8elCFak4ZI_Gs4nYko11ip&uniplatform=NZKPT.

9.黄卓敏, 许军, 许梦瑶, 等. 创新药品价值评价指标体系构建[J]. 中国卫生资源, 2022, 25(2): 244-249.[Huang ZM, Xu J, Xu MY, et al. Construction of evaluation index system for innovative drug value[J]. China Health Resources, 2022, 25(2): 244-249.] DOI: 10.13688/j.cnki.chr.2022.210429.

10.国家卫生健康委办公厅.药品临床综合评价管理指南(2021年版试行)[EB/OL]. (2021-07-08) [2022-07-27].http//www.nhc.gov.cn/yaozs/s2908/202107/532e20800a47415d84adf3797b0f4869.shtml.

11.赵志刚, 董占军, 刘建平. 中国医疗机构药品评价与遴选快速指南[J]. 医药导报, 2020, 39(11): 1457-1465. [Zhao ZG, Dong ZJ, Liu JP. Quick guide to drug evaluation and selection in Chinese medical institutions[J]. Herald of Medicine, 2020, 39(11): 1457-1465.] DOI: 10.3870/j.issn.1004-0781.2020.11.001.

12.卫生部办公厅关于印发《鼠疫诊疗方案(试行)》的通知[J]. 中华人民共和国国家卫生和计划生育委员会公报, 2011, (3): 49-57.

13.孙昱.新发传染病相关的药品技术战略储备思考[J]. 中国药事, 2020, 34(3): 266-274. [Sun Y. Thinking on the strategic reserve of drug technology related to emerging infectious diseases[J]. Chinese Pharmaceu-tical Affairs, 2020, 34(3): 266-274.] DOI: 10.16153/j.1002-7777.2020.03.003.